Abstract
Question: A 35-year-old woman in her third trimester of pregnancy presented to the emergency department for fever and abdominal pain. Her past medical history consisted of ileal Crohn’s disease (CD) diagnosed 10 years ago and active smoking (without cessation during pregnancy). After failure of azathioprine and adalimumab, she was treated with infliximab for 1 year (7.5 mg/kg of body weight every 6 weeks) and considered in remission at the beginning of her pregnancy. As recommended by European Crohn’s and Colitis Organisation guidelines, the tumor necrosis factor (TNF)-α antagonist was discontinued at gestational week 26 (aiming at limiting the fetal exposure).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
